Etiology and management of Alzheimer's disease: Potential role of gut microbiota modulation with probiotics supplementation. Issue 1 (19th December 2021)

• Record Type: Journal Article
• Authors: Lekchand Dasriya, Vaishali; Samtiya, Mrinal; Dhewa, Tejpal; Puniya, Monica; Kumar, Sanjeev; Ranveer, Soniya; Chaudhary, Vishu; Vij, Shilpa; Behare, Pradip; Singh, Namita; Aluko, Rotimi E.; Puniya, Anil Kumar
• Is Part Of: Journal of food biochemistry. Volume 46:Issue 1(2022)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2021-12-19
• Subjects: Alzheimer's disease -- brain health -- dementia -- gut microbiota -- immune functions -- oxidative stress -- probiotics; Food -- Analysis -- Periodicals; Food -- Composition -- Periodicals; Biochemistry -- Periodicals; 664.024
• DOI: 10.1111/jfbc.14043
• Languages: English
• ISSNs: 0145-8884

Abstract

Abstract: Alzheimer's disease (AD) is the leading type of dementia in aging people and is a progressive condition that causes neurodegeneration, resulting in confusion, memory loss, and deterioration of mental functions. AD happens because of abnormal twisting of the microtubule tau protein in neurons into a tangled neurofibrillary structure. Different factors responsible for AD pathogenesis include heavy metals, aging, cardiovascular disease, and environmental and genetic factors. Market available drugs for AD have several side effects that include hepato‐toxicity, accelerated cognitive decline, worsened neuropsychiatric symptoms, and triggered suicidal ideation. Therefore, an emerging alternative therapeutic approach is probiotics, which can improve AD by modulating the gut‐brain axis. Probiotics modulate different neurochemical pathways by regulating the signalling pathways associated with inflammation, histone deacetylation, and microglial cell activation and maturation. In addition, probiotics‐derived metabolites (i.e., short‐chain fatty acid, neurotransmitters, and antioxidants) have shown ameliorative effects against AD. Probiotics also modulate gut microbiota, with a beneficial impact on neural signalling and cognitive activity, which can attenuate AD progression. Therefore, the current review describes the etiology and mechanism of AD progression as well as various treatment options with a focus on the use of probiotics. Practical applications: In an aging population, dementia concerns are quite prevalent globally. AD is one of the most commonly occurring cognition disorders, which is linked to diminished brain functions. Scientific evidence supports the findings that probiotics and gut microbiota can regulate/modulate brain functions, one of the finest strategies to alleviate such disorders through the gut‐brain axis. Thus, gut microbiota modulation, especially through probiotic supplementation, could become an effective solution to ameliorate AD.